Boston, MA, United States of America

Jose Aramburu


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jose Aramburu

Introduction

Jose Aramburu is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of immune-related diseases. With a total of 2 patents, his work has had a profound impact on the understanding and treatment of various conditions.

Latest Patents

Aramburu's latest patents focus on specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases. These patents describe isolated peptide fragments of the conserved regulatory domain of the NFAT protein, which are capable of inhibiting the protein-protein interaction between calcineurin and NFAT. Additionally, the patents detail isolated polynucleotides and gene therapy vectors encoding such peptide fragments. Methods for treating immune-related diseases or conditions, as well as high throughput screening of candidate agents, are also outlined. Furthermore, pharmaceutical compositions related to these innovations are provided.

Career Highlights

Throughout his career, Jose Aramburu has worked with esteemed organizations such as the Immune Disease Institute, Inc. and the CBR Institute for Biomedical Research, Inc. His research has contributed to advancements in the understanding of immune responses and therapeutic approaches.

Collaborations

Aramburu has collaborated with notable colleagues, including Patrick Hogan and Anjana Rao. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the biomedical field.

Conclusion

Jose Aramburu's contributions to the field of biomedical research, particularly through his patents and collaborations, highlight his commitment to advancing the treatment of immune-related diseases. His work continues to inspire future innovations in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…